Ekso Bionics
EKSOPrivate Company
Total funding raised: $60M
Overview
Ekso Bionics is a leader in robotic exoskeleton technology with a mission to enhance, amplify, and restore human function. Founded in 2005, the company has achieved commercial scale with its medical devices deployed in over 500 rehabilitation centers globally and has secured a pivotal Medicare coverage determination for its personal use device. Its strategy focuses on expanding clinical indications, driving insurance reimbursement, and leveraging its modular technology platform across healthcare and industrial markets.
Technology Platform
A modular, powered exoskeleton platform integrating lightweight robotics, adaptive sensor-based software algorithms, and data analytics, designed to restore mobility in clinical and personal settings and augment human strength in industrial applications.
Funding History
4Company Timeline
Founded in Richmond, United States
Series A: $8.0M
Series B: $20.0M
IPO — $30.0M